Long Trade in EXAS

Exact Sciences is a biotech stock showing high relative strength.

Following a 50% jump in January, the stock is tightening with pullbacks getting shallower from left to right.

This is a sign of seller digestion which we often see before a new breakout to the upside.

EXAS is also finding support at key moving averages which appear to be holding up the stock.

I would consider buying on a breakout above $69.